Clinical Trials on 眼睑肿瘤 in United Kingdom
总计49681个结果
-
Robert Redner, MDPfizer主动,不招人
-
University of Maryland, Baltimore主动,不招人
-
National Cancer Institute (NCI)主动,不招人
-
Royal Surrey County Hospital NHS Foundation Trust招聘中
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI)主动,不招人慢性粒单核细胞白血病 | 骨髓增生异常综合症 | 骨髓增生异常/骨髓增生性肿瘤 | 最小残留病 | 骨髓增生异常/骨髓增生性肿瘤,无法分类 | 缓解期急性髓性白血病美国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
Maxim Pharmaceuticals完全的
-
Brown UniversityPfizer; The Miriam Hospital; Rhode Island Hospital主动,不招人
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)完全的
-
Daiichi Sankyo, Inc.Ambit Biosciences Corporation完全的
-
Celularity Incorporated终止
-
Teva Branded Pharmaceutical Products R&D, Inc.Cephalon; ChemGenex Pharmaceuticals完全的慢性粒细胞白血病美国, 加拿大, 法国, 德国, 匈牙利, 印度, 意大利, 波兰, 新加坡, 英国
-
Children's Hospital Medical Center, Cincinnati招聘中
-
M.D. Anderson Cancer CenterAstex Pharmaceuticals, Inc.; Syndax Pharmaceuticals招聘中
-
Oxford University Hospitals NHS TrustUniversity of Oxford完全的
-
National Cancer Institute (NCI)主动,不招人
-
Nohla Therapeutics, Inc.National Cancer Institute (NCI); Fred Hutchinson Cancer Center终止
-
Bhavana BhatnagarCTI BioPharma完全的
-
SGM Physician Research ConsortiumMusculoskeletal Transplant Foundation完全的
-
University of Colorado, DenverKaryopharm Therapeutics Inc招聘中
-
PersImmune, IncUniversity of California, San Diego未知
-
University of California, San DiegoJazz Pharmaceuticals终止
-
University of Maryland, Baltimore主动,不招人
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.招聘中急性髓性白血病 | 治疗相关的急性髓性白血病 | 血液和淋巴细胞疾病 | 缓解期急性髓性白血病 | FLT3基因突变 | 最小残留病持续存在美国
-
University of Rochester招聘中
-
University of Southern CaliforniaNational Cancer Institute (NCI)招聘中
-
Queen Mary University of LondonUniversity College London Hospitals招聘中
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)完全的